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... diet is the mother of diseases, let the father be what he will; and from this alone melancholy and frequent other maladies arise.
-Fernelius [Burton 1927, p. 189] Medical geology compares the geographic distribution of disease with trace element geology (Hemphill 1968-75; Cannon and Hopps 1971; Hopps and Cannon 1972; National Academy of Sciences 1974 , 1977 Freedman 1975; Bowie and Thornton 1985) . The basic assumption is that deficiencies or excesses of trace elements in food and water can cause disease. Diet taken from a given region can reflect concentrations of elements in the soil and bedrock in that region (Cannon and Hopps 1971; Hopps and Cannon 1972) . Therefore, disease and geology can be correlated. Diseases with variable geographic epidemiology include goiter, cancer, heart disease, neonatal death, multiple sclerosis, dental caries and Itai-Itai disease (Carroll 1966; Ludwig and Bibby 1969; Cowgill 1975; Lay ton and Sutherland 1975; Strain et al. 1975; Kobayashi 1978 ; National Academy of Sciences 1978 Sciences , 1979 Neri et al. 1985; Foster 1986; Hasanen et al. 1986) .
The confirmation of an environmental cause for a disease must demonstrate strength, consistency, specificity, temporality, biological gradient, plausibility, coherence, experimental evidence, and analogy (Underwood 1971; National Research Council 1991) . These nine conditions must be met to avoid errors that arise when multiple trace elements are involved and when soil concentrations of elements are assumed to be passed on to living organisms through the food chain. These issues are extensively reviewed elsewhere (Cannon and Hopps 1971; Hopps and Cannon 1972; Freedman 1975 ) and will not be reviewed here. If these requirements are not met, erroneous conclusions can result in unfounded or fraudulent therapies, such as unique diets and healing crystals. Medical geology is valued for generating testable hypotheses based on geologic and clinical observations. Lithium. In his article on the treatment of mania with lithium, Cade (1949) speculated that lithium in certain British well waters was responsible for the waters' "special virtue in the treatment of mental illness" (p. 350). In 1885, waters in Mineral Wells, Texas, established the same reputation, when lithiumbearing water from a local well "cured" travelers of "hysterical mania." By 1920 this well, named the "Crazy Well," (Mineral Wells Index 1929; Webb 1952) was the center of a large health resort with hundreds of wells, a bottling plant, and thousands of annual visitors seeking to be healed by "Crazy Water." One Texas county applied for a permit for a sanatorium on the basis of the belief that local waters produced psychiatric cures (Fowler 1991) . Forty years later, Dawson et al. (1970) reported that the high lithium concentration in Texas drinking water led to low rates of psychiatric admissions from certain counties. The debate ended after Pokorny et al. (1972) demonstrated that this association lacked control for diagnosis, population differences, and distance to mental hospitals. Furthermore, a broader study of "affective psychoses" in U.S. cities near lithium deposits found no relationship between psychiatric admissions and proximity to the deposits (Steinberg and Rosin 1970) . Aluminum. After aluminum was found in neuritic plaques in the brains of Alzheimer's disease patients, environmental exposure to aluminum was theorized to have a role in the disease's etiology. Martyn et al. (1989) positively correlated aluminum levels in drinking water with Alzheimer's disease rates in Britain. Neri and Hewitt (1991) made the same finding in Ontario, Canada. The issue remains controversial, since the aluminum in the neuritic plaques might have resulted from contamination of specimens (Landsberg et al. 1992) . If so, correlations of environmental aluminum with Alzheimer's disease would require reexamination.
Geography of Schizophrenia
The cause of the well-known geographic variability of schizophrenia in the United States has not been established. Torrey and Bowler (1990) reviewed this geographic distribution and demonstrated its stability over time. They concluded that "urban factors" might account for the findings. However, while the "social drift hypothesis" appears to explain the presence of persons with schizophrenia in poor areas of large cities, Torrey and Bowler argue that most States with a high prevalence of schizophrenia are not likely targets of migration (e.g., New Jersey and Wisconsin).
Urban factors associated with high schizophrenia rates include "industrialization," which Torrey and Bowler credited Foster (1988) for previously correlating with schizophrenia. They failed to mention that Foster's highest correlation coefficient (0.58) for high rates of schizophrenia was for lowselenium crops rather than urbanization. Foster speculated that low selenium levels might result in reduced prostaglandin synthesis previously described as abnormal in schizophrenia patients.
Association Between Selenium Deficiency and Schizophrenia
Strength. The extent of selenium deficiency in crops in the United States (figure 1) is well known (Oldfield 1974 ) because large numbers of livestock are at risk for white muscle disease, a fatal selenium-deficiency disease (Kubota et al. 1967 ). In the 1970s, selenium supplementation of livestock feed in the United States started to prevent this disease. The distribution of low selenium levels shown in figure 1 has been reproduced in studies of selenium in human milk (Shearer and Hadjimarkos 1975) and blood (Allaway et al. 1968) . Comparing the distribution of lowselenium areas with that of schizophrenia can test the strength of the association. Torrey and Bowler (1990) provided maps of prevalence rates of schizophrenia for 1880, 1890, 1903, 1910, 1923, 1933, 1943, 1953, and 1963 )-There is even a significant correlation for States that reported high or very high schizophrenia rates in at least five of the nine surveys (figure 3) (p < 0.002). In fact, there is a significant correlation (p < 0.0001) between not only the 1880 survey but also the 1963 survey and the lowselenium States in figure 1 . Cowgill (1975) found that 77.5 percent of the low-selenium areas were urban but only 67.8 percent of the high-selenium areas were urban. One might speculate that the association of schizophrenia with urban areas is due not to urban factors but to the fact that the cities are located in and surrounded by low-selenium areas.
One way to directly test the association between low selenium levels and schizophrenia is to measure selenium in schizophrenia patients. Two such investigations failed to find reduced selenium levels in schizophrenia patients. Tada et al. (1986) found elevated levels of selenium in the hair of male, but not female, patients. Alertsen et al. (1986) found that serum and blood selenium levels in a group of Norwegians with schizophrenia was no different from those in normal subjects. However, if schizophrenia results from a prenatal or childhood exposure, the significance of selenium studies in adults with schizophrenia is questionable. Furthermore, since the relationship between hair and total body selenium levels is unknown, and since selenium measurement is technically difficult, there is significant uncertainty in interpreting hair analysis (Cheng et al. 1990 ). Consistency. One can assess the consistency of the association by comparing the rates of schizophrenia in high-and low-selenium countries. Maps of selenium levels in cereal crops in European countries are available (Gissel-Nielsen et al. 1984; Adriano 1986) . Sweden, Norway, and Finland have less soil selenium than other European countries (Adriano 1986).
The Finnish selenium level is so low that, starting in 1969, the population required selenium supplementation through additives to fertilizers and animal feeds (Alfthan et al. 1989) . If the theory is correct, one should find high schizophrenia rates in Finland that have decreased following supplementation. The theory is supported by the high point prevalence in Finland of 13 to 15 per 1,000. This is the highest consistently reported point prevalence in Europe (Jablensky 1986; Lehtinen et al. 1990 ).
Furthermore, Lehtinen et al. (1990) found that schizophrenia prevalence in Finland was highest in the 50-54 age group and diminished with decreasing age. However, such supporting evidence is nonspecific, since prevalence has also decreased in countries such as Denmark that have low soil selenium levels but no extensive selenium supplementation (Jorgensen and Mortensen 1992) . Oster and Prellwitz (1989) reported that West Germany had lower soil selenium levels than Finland. Comparable schizophrenia indices are not available for West Germany and Finland. However, the incidence of schizophrenia in West Germany was twice that in Norway, where incidence rates are a "reasonable estimate of schizophrenia in European populations" (Jablensky 1986 ). Since Norwegian blood levels of selenium are above average despite low levels in crops (Meltzer et al. 1989) , this finding appears to support the association of low blood selenium levels with high schizophrenia rates. However, West German blood levels of selenium are unknown and could also be higher than the reported soil selenium levels would suggest.
New Zealand has severely deficient soil selenium (Gissel-Nielsen et al. 1984) . Livestock supplementation started in 1960 (P.J. O'Hara, New Zealand Ministry of Agriculture and Fisheries, personal communication, 1992) and was followed by fertilizer supplementation in the late 1970s (Watkinson 1983) . Schizophrenia rates before 1970 are not available, and pre-and postsupplementation rates cannot be compared. However, New Zealand's current lifetime prevalence of schizophrenia is 0.4 percent, which is as low as the lowest morbid risk rates in Europe (Jablensky 1986; Wells et al. 1989 ). Joyce (1987) found that first admissions for schizophrenia have been dropping since 1974 but attributed this finding to an actual decrease in the incidence of schizophrenia rather than a nosologic change. Although the hypothesis is not supported by the low incidence of schizophrenia in a lowselenium country, it is supported by the decreasing incidence of schizophrenia in postsupplementation years. Unfortunately, this argument provides no consistent support for the same reason discussed above for Finland: Schizophrenia diminished during this time in nonsupplemented countries. The consistency of the selenium theory cannot be clearly demonstrated.
Specificity and Analog. For the theory to be supported, selenium deficiency should be associated with diseases that are associated with schizophrenia. Furthermore, selenium should be the only trace element with this association.
Kaschin-Beck and Keshan disease. Two selenium-deficiency diseases are thought to occur in humans: Kaschin-Beck disease, an osteoarthropathy (Sokoloff 1987), and Keshan disease, a cardiomyopathy (Laryea et al. 1989) . Neither is associated with psychiatric symptoms, but both are known only in endemic areas of China and are not found in areas of even more profound selenium deficiency (Sokoloff 1987; Laryea et al. 1989) , so additional factors seem to be involved. However, a comparison of rates of schizophrenia, Kaschin-Beck disease, and Keshan disease in selenium-deficient provinces in China would test the specificity of the association between low selenium levels and schizophrenia.
Multiple sclerosis (MS). Because of similarities in geographic distribution and other epidemiologic characteristics between MS and schizophrenia, Stevens (1988) suggested that these two diseases belong to a similar class of disorders sharing an infectious or immunologic cause. For example, the northern areas of the United States that have high schizophrenia rates also have high MS rates (Templer et al. 1985) . If these diseases are related and if the selenium theory is correct, then selenium deficiency should be found in association with high MS rates. Such a theory was proposed by Schalin (1980) , who found low soil selenium levels in high-MS regions (Hasanen et al. 1986 ). Another theory concerning the geographic distribution of MS proposed that high soil molybdenum levels were responsible for high MS rates in New Zealand, Finland, and parts of the United States (Layton and Sutherland 1975) . This theory's fundamental assumption was not supported by Welch et al. (1991) , who found high molybdenum levels only in the Western United States, not in the Northern States where MS risk is highest.
Other diseases. Low selenium levels are also correlated with the geography of low birthrates (Cowgill 1975) and high rates of dental caries (Ludwig and Bibby 1969) . Low birth weight, obstetrical complications, and skeletal abnormalities are associated with schizophrenia (Fish et al. 1992 ), but geographic distribution of dental caries and birthrates in schizophrenia patients have not been investigated.
Other trace elements. Various trace elements may be involved in schizophrenia, and some-such as zinc, iron, chromium, and strontium-are associated with the geography of MS in Finland (Hasanen et al. 1986 ). Low zinc and high copper levels were reported in the serum of schizophrenia patients (Srinivasan 1984; Lohr 1991) . Others found abnormalities in manganese (Srinivasan 1984) , magnesium (Tada et al. 1986 ), nickel (Nielsen 1977) , and iron (Lohr 1991) . Do other trace element distributions share selenium's strong, statistically significant geographic correlation with schizophrenia?
In the 1970s, the United States Geological Survey (USGS) published elemental composition maps of "surficial material" in the United States (Shacklette et al. 1971a (Shacklette et al. , 1971b (Shacklette et al. , 1973 (Shacklette et al. , 1974 . These maps of 35 elements were based on 863 sample sites spaced at 50-mile intervals throughout the United States (Kubota 1978) . The elements included those of neuropsychiatric significance: copper, zinc, aluminum, lithium, selenium, lead, mercury, manganese, nickel, and others. It is tempting to use such information for medical geology; however, soil profiles are not significant unless they are reflected in vegetation and ultimately in the human body. The USGS selenium map exemplifies this problem: It shows low soil selenium levels in some areas of high-selenium crops. The presence of selenium-accumulator plants in areas with low soil selenium is responsible for this contradiction (Kubota et al. 1967) . Such confounding factors render these maps unusable for this study.
Trace element distribution in the surface waters of the United States can be compared with schizophrenia rates as well. In 1968 the Federal Water Pollution Control Administration published mean values for 19 trace metals for the 15 major river basins in the United States (Kopp and Kroner 1968) , but these values do not reflect water supplies that would be consumed by most urban residents. Durfor and Becker (1962) published trace element concentrations found in the water supplies of the 100 largest U.S. cities, but this information of Durfor and Becker has limited applicability to this study because the 100 largest cities are located in only 38 States. However, the water quality of the largest cities in high-schizophrenia States can be compared with that of the largest cities in low-schizophrenia States. Arithmetic means were calculated for beta activity, aluminum, barium, chromium, lithium, nickel, lead, rubidium, and strontium for high-and low-schizophrenia States. Means for aluminum, barium, chromium, lead, rubidium, and strontium were un-VOL. 20, NO. 2, 1994 393 expectedly higher in the low-schizophrenia States. The mean for lithium was also higher in the low-schizophrenia States, and those for nickel and beta activity were higher in the high-schizophrenia States. Beta activity represented emission of beta particles from naturally occurring strontium and contamination from nuclear weapon testing and nuclear power plants. If no connection is demonstrated with levels in human blood, this data cannot be used. The reason why lithium is different from other elements in having higher mean levels in lowschizophrenia States is unknown.
There are studies of trace element distributions in vegetation or human blood. Kubota (1968) mapped cobalt deficiency in forage and soils of the United States. Low cobalt levels are limited to areas in New England, northern Michigan, Iowa, and Florida. This distribution does not significantly correlate with high-schizophrenia areas. Berger (1962) investigated deficiencies of boron, copper, iron, manganese, molybdenum, and zinc in crops. Two-by-two tables comparing States low in boron, iron, manganese, or zinc with highschizophrenia States revealed no significant correlation. The correlation between high-schizophrenia States and those whose crops were low in molybdenum (figure 4) or copper (figure 5) was significant (p < 0.02). However, human blood levels of molybdenum and copper demonstrate no geographic pattern . Similar studies of vanadium, cadmium, and lead in human blood from blood donors in the United States found no geographic pattern (Allaway et al. 1968; Kubota et al. 1968) . Although serum zinc levels in human blood decrease from north to south in the Eastern United States ), this finding is contrary to zinc deficiency theories of schizophrenia, since schizophrenia rates also decrease from North to South.
Other maps showing the distribution of surface and groundwater hardness, treated and untreated (Angino 1978) , and metal ion precipitation (Lazrus et al. 1970) show no visual correlation with schizophrenia rates. Finally, geologic sources of radioactivity (Cannon 1978) show no visual correlation with schizophrenia rates. Low selenium levels thus appear to be more specifically correlated with schizophrenia than are other trace element deficiencies or excesses.
Biological Gradient. The highest schizophrenia rates should be found in the lowest selenium areas. In the United States the lowest selenium States are Florida, Oregon, and Washington. The remaining low-selenium States are generally equal in their selenium levels. Since Florida, Oregon, and Washington do not have the highest schizophrenia rates, a biological gradient of the association is not established.
Schizophrenia is most common in eastern and northern Finland (Lehtinen et al. 1990 ). Biological gradient could be further tested if the distribution of selenium in Finland were known.
Plausibility and Coherence. The association of low selenium levels with high rates of schizophrenia is plausible and coherent with several biological facts about schizophrenia. First, glutathione peroxidase is a selenoprotein that detoxifies free radicals, which are theorized to be important in the pathogenesis of schizophrenia (Lohr 1991) . Second, glutathione peroxidase is involved in the arachidonic acid cascade. Selenium supplementation in humans allows the reduction of the lipoxygenase-derived 8, 11, 8, 11, (van der Torre et al. 1989) . 12-HPETE thus accumulates in selenium deficiency (Bryant et al. 1983) . The arachidonic acid cascade, including 12-HPETE and 12-HETE, is under investigation for its role in modulating N-methyl-D-aspartate-sensitive glutamate receptors, which are implicated in neurodegenerative diseases (Marangos and Lai 1992) . Furthermore, Schoene et al. (1986) suggested that selenium deficiency impairs platelet activation by decreasing the activity of glutathione peroxidase, thus allowing increased injury from inflammatory agents. Third, Lohr (1991) reported a negative correlation between glutathione peroxidase activity and brain activity in schizophrenia. Finally, Suttle and Jones (1989) reported that deficient glutathione peroxidase is associated with immune cell dysfunction in seleniumdeficient ruminants. Although this dysfunction may not directly result in reduced resistance to infection (Suttle and Jones 1989) , the coexistence of urban crowding and selenium deficiency might promote a viral etiology of schizophrenia, especially if the deficiency further promotes continued inflammation and brain damage.
Temporality. The requirement of temporality stipulates that (1) the exposure to a causative agent must occur within a reasonable interval before the development of the symptoms and (2) the time between exposure and symptoms must be consistent with known characteristics of the disease (National Research Council 1991). Schizophrenia appears to be a disease that presents years after exposure to the causative agent or agents. It can only be speculated how long, at what age, and under what circumstances an individual would need to be exposed to a selenium-deficient diet to develop schizophrenia. For example, could schizophrenia result from a viral infection followed by years of a selenium-deficient diet?
Experimental Evidence. The theory has not been tested by experiment. One possible test is to identify infants with and without obstetric or viral complications. A prospective comparison of the schizophrenia rates and dietary intake of selenium by these infants would test the hypothesis.
Conclusion
This examination does not fully support the selenium theory of schizophrenia. Some proof is lacking because of missing or limited data for consistency, biological gradient, temporality, and experimental evidence (see table 2). Given 
